CreativeOne Wealth’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,093
Closed -$1.16M 1202
2025
Q3
$1.16M Sell
6,093
-1,214
-17% -$215K 0.03% 489
2025
Q2
$1.31M Buy
7,307
+898
+14% +$156K 0.03% 459
2025
Q1
$1.08M Sell
6,409
-71
-1% -$11.7K 0.03% 457
2024
Q4
$977K Buy
6,480
+1,137
+21% +$177K 0.03% 478
2024
Q3
$829K Buy
5,343
+2,434
+84% +$364K 0.03% 490
2024
Q2
$398K Sell
2,909
-2,299
-44% -$315K 0.02% 535
2024
Q1
$694K Buy
5,208
+2,019
+63% +$262K 0.03% 472
2023
Q4
$440K Sell
3,189
-4,786
-60% -$629K 0.03% 399
2023
Q3
$972K Sell
7,975
-6,934
-47% -$924K 0.07% 242
2023
Q2
$2.1M Buy
14,909
+5,649
+61% +$779K 0.1% 200
2023
Q1
$1.31M Sell
9,260
-612
-6% -$87.6K 0.06% 262
2022
Q4
$1.54M Sell
9,872
-982
-9% -$141K 0.09% 207
2022
Q3
$1.33M Buy
10,854
+7,673
+241% +$1.01M 0.08% 212
2022
Q2
$423K Sell
3,181
-145
-4% -$19.8K 0.02% 454
2022
Q1
$455K Buy
3,326
+257
+8% +$35.8K 0.02% 456
2021
Q4
$531K Buy
3,069
+216
+8% +$32.9K 0.03% 439
2021
Q3
$415K Buy
2,853
+549
+24% +$80.3K 0.02% 454
2021
Q2
$304K Buy
2,304
+699
+44% +$91.5K 0.02% 530
2021
Q1
$206K Sell
1,605
-407
-20% -$50.2K 0.02% 534
2020
Q4
$240K Buy
+2,012
New +$245K 0.02% 437

Other funds holding DGX

CreativeOne Wealth's DGX Position: Q4 2025 in Review

CreativeOne Wealth sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 6,093 shares — an estimated $1.16M sold.

CreativeOne Wealth first reported a position in DGX in Q4 2020 and held it in 20 quarters. The position peaked at $2.1M in Q2 2023. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • CreativeOne Wealth reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • CreativeOne Wealth sold 6,093 Quest Diagnostics shares in Q4 2025, an estimated $1.16M.
  • CreativeOne Wealth first reported a position in Quest Diagnostics in Q4 2020 and held it in 20 quarters.
  • CreativeOne Wealth's Quest Diagnostics position peaked at $2.1M in Q2 2023.
  • 1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on CreativeOne Wealth's 13F filing for Q4 2025, filed 13 Feb 2026.